FDA — authorised 2 August 2004
- Application: NDA021752
- Marketing authorisation holder: GILEAD
- Local brand name: TRUVADA
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Emtricitabine / Tenofovir Disoproxil Oral Tablet in United States
FDA authorised Emtricitabine / Tenofovir Disoproxil Oral Tablet on 2 August 2004
Marketing authorisation
Other Infectious Disease / Virology approved in United States
Frequently asked questions
Is Emtricitabine / Tenofovir Disoproxil Oral Tablet approved in United States?
Yes. FDA authorised it on 2 August 2004.
Who is the marketing authorisation holder for Emtricitabine / Tenofovir Disoproxil Oral Tablet in United States?
GILEAD holds the US marketing authorisation.